Previous Chapter Chapter 9: The Changing Face of European Drug Registration Next Chapter

By: Decision Resources Inc

In: The SAGE Handbook of Healthcare

Chapter 9: The Changing Face of European Drug Registration

  • Citations
  • Add to My List
  • Text Size

The Changing Face of European Drug Registration
The changing face of european drug registration
Introduction

Until the mid-1990s, drug registration in Europe was the prerogative of regulatory authorities in each country. On January 1, 1995, however, the countries of the European Economic Area (EEA) (the member states of the European Union [EU] plus Iceland, Liechtenstein, and Norway) inaugurated the European Agency for the Evaluation of Medicinal Products (commonly known as the European Medicines Evaluation Agency [EMEA]). The European Commission states that the EMEA is charged with “pooling the scientific expertise of member states in order to ensure a high degree of protection for public health, ensuring free movement of pharmaceuticals, and making certain that Europeans have access to new generations of medicinal products.” The creation of the ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website